Timing of Transcutaneous Acupoint Electrical Stimulation on Postoperative Recovery in Geriatric Patients with Gastrointestinal Tumor

Launched by SUBEI PEOPLE'S HOSPITAL OF JIANGSU PROVINCE · Jul 28, 2022

Keywords

ClinConnect Summary

This clinical trial is investigating the best timing for a treatment called Transcutaneous Electrical Acupoint Stimulation (TEAS) to help older patients recover after surgery for gastrointestinal tumors. Postoperative cognitive dysfunction (POCD) is a common problem in these patients, leading to issues like memory loss and difficulty concentrating. The study aims to find out when TEAS is most effective in improving cognitive function and reducing the risk of POCD, which can impact recovery and overall quality of life.

To participate in this trial, patients must be 60 years or older, diagnosed with a gastrointestinal tumor, and scheduled for surgery at Subei People's Hospital. They should also be in generally good health, without a history of severe cognitive issues or certain medical conditions. Participants can expect to receive TEAS treatment at different times around their surgery and will be monitored for improvements in their cognitive function and recovery. This research could help improve postoperative care for older patients and reduce the long-term effects of surgery on their mental health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged 60 years or older.
• • Patients diagnosed with gastrointestinal tumor and received radical resection of gastrointestinal tumors under general anesthesia in Subei People's Hospital of Jiangsu province.
• • Patients willing and able to give informed consent and comply with this study protocol.
• • American Society of Anesthesiology (ASA) classification I～III. ⑤ Preoperative Tilburg frailty scale score is less than 5 points. ⑥ Preoperative D-dimer was normal.
• Exclusion Criteria:
• • Preoperative cognitive dysfunction or history of cognitive dysfunction, dementia, and delirium.
• • History of severe depression, schizophrenia, or other mental and nervous system diseases or taking antipsychotic or antidepressant drugs in the past.
• • Patients with severe hearing or visual impairment without assistive tools.
• • Patients who have difficulty in communicating.
• • Male patients average daily pure alcohol intake ≥ 61 g or female patients average daily pure alcohol intake ≥ 41 g.
• • Patients received surgical treatment within 3 months or preoperative hospitalized over 3 months.
• • Patients with severe heart, liver, or renal failure.
• • ⑧ Patients with hypoxemia (blood oxygen saturation \< 94%) more than 10 min during the operation.
• • ⑨ Patients admitted to ICU after operation.
• • ⑩ Patients who quit or died due to noncooperation or sudden situation.
• • ⑪ Patients who already participate in other clinical studies which may influence this study.
• • ⑫ Patients who underwent emergency surgery.
• • ⑬ Patients who had a history of acupuncture treatment.